APA (7th ed.) Citation

TH, H., HP, K., CH, P., YC, L., BJ, L., MC, C., & CH, C. (2026). A cyclin D1-CDK4/6-E2F dependency represents an acquired vulnerability in cisplatin-resistant bladder cancer. Biology direct, 21(1), . https://doi.org/10.1186/s13062-026-00812-5

Chicago Style (17th ed.) Citation

TH, Hsieh, Kuo HP, Pan CH, Lin YC, Lin BJ, Chen MC, and Chen CH. "A Cyclin D1-CDK4/6-E2F Dependency Represents an Acquired Vulnerability in Cisplatin-resistant Bladder Cancer." Biology Direct 21, no. 1 (2026). https://doi.org/10.1186/s13062-026-00812-5.

MLA (9th ed.) Citation

TH, Hsieh, et al. "A Cyclin D1-CDK4/6-E2F Dependency Represents an Acquired Vulnerability in Cisplatin-resistant Bladder Cancer." Biology Direct, vol. 21, no. 1, 2026, https://doi.org/10.1186/s13062-026-00812-5.